Your browser doesn't support javascript.
loading
Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation.
Jan, Max; Leventhal, Matthew J; Morgan, Elizabeth A; Wengrod, Jordan C; Nag, Anwesha; Drinan, Samantha D; Wollison, Bruce M; Ducar, Matthew D; Thorner, Aaron R; Leppanen, Scott; Baronas, Jane; Stevens, Jonathan; Lane, William J; Kekre, Natasha; Ho, Vincent T; Koreth, John; Cutler, Corey S; Nikiforow, Sarah; Alyea, Edwin P; Antin, Joseph H; Soiffer, Robert J; Ritz, Jerome; Lindsley, R Coleman; Ebert, Benjamin L.
Afiliação
  • Jan M; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Leventhal MJ; Department of Pathology, Massachusetts General Hospital, Boston, MA.
  • Morgan EA; Broad Institute, Cambridge, MA.
  • Wengrod JC; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Nag A; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Drinan SD; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA.
  • Wollison BM; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA.
  • Ducar MD; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA.
  • Thorner AR; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA.
  • Leppanen S; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA.
  • Baronas J; Agilent Technologies, Santa Clara, CA.
  • Stevens J; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Lane WJ; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Kekre N; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Ho VT; Ottawa Blood Disease Centre, The Ottawa Hospital, Ottawa, ON, Canada; and.
  • Koreth J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Cutler CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Nikiforow S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Alyea EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Antin JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Lindsley RC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Ebert BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
Blood Adv ; 3(14): 2199-2204, 2019 07 23.
Article em En | MEDLINE | ID: mdl-31324640
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Deleção de Genes / Transplante de Células-Tronco Hematopoéticas / Antígenos HLA Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Marrocos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Deleção de Genes / Transplante de Células-Tronco Hematopoéticas / Antígenos HLA Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Marrocos